It is the overall aim of this research program to understand genetic networks and to integrate the genetics of complex traits with the importance of intermediary metabolism in mammals. Thus, my laboratory has two long-term goals: 1) to identify and characterize all genes involved in human galactose metabolism and 2) to delineate the fundamental importance of galactose metabolism in mammalian development, homeostasis and disease. Galactose is a major component of milk sugar, yet its role in normal development and function is unknown. Galactosemia refers to three inherited disorders of galactose metabolism secondary to deficiency of any one of the enzymes of human galactose metabolism. Deficiency of uridine diphospho-galactose (UDP-gal)4'- epimerase (GALE) can involve in its acute form liver disease, failure to thrive and cataract formation. These symptoms, however, disappear upon the institution of a galactose restricted diet. GALE is expressed ubiquitously and the general form of epimerase-deficiency galactosemia involves all tissues. Peripheral GALE-deficiency is very common and is characterized by erythrocytic enzyme deficiency alone. It is usually not associated with any symptoms. The molecular basis of epimerase- deficiency galactosemia is a present completely unknown. We wish to undertake molecular studies to define the genetic basis of both general and peripheral epimerase-deficiency galactosemia. To this end, we will investigate the following two specific aims: 1) clone and characterize a full-length human cDNA and the gene encoding GALE and 2) characterize the molecular genetic basis of epimerase-deficiency galactosemia. Since galactose metabolism is biochemically well understood it is now ripe for molecular analysis. The cloning and characterization of human GALE will open new avenues for research into the molecular basis of epimerase-deficiency galactosemia, a metabolic liver disease. Our proposed studies will be of great significance in understanding the fundamental importance of human galactose metabolism and its associated diseases.

Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753
Zhang, Chunying; Niu, Chao; Yang, Kevin et al. (2018) Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth. Sci Rep 8:12354
Tsai, Yuan-Li; Ha, Dat P; Zhao, He et al. (2018) Endoplasmic reticulum stress activates SRC, relocating chaperones to the cell surface where GRP78/CD109 blocks TGF-? signaling. Proc Natl Acad Sci U S A 115:E4245-E4254
Chen, Jingwen; Lam, Albert T; Zhang, Yong (2018) A macrodomain-linked immunosorbent assay (MLISA) for mono-ADP-ribosyltransferases. Anal Biochem 543:132-139
Chang, Huiyi H; Yeh, Jih-Chao; Ichiyama, Ronaldo M et al. (2018) Mapping and neuromodulation of lower urinary tract function using spinal cord stimulation in female rats. Exp Neurol 305:26-32
Chen, Chien-Yu; Chen, Jingyu; He, Lina et al. (2018) PTEN: Tumor Suppressor and Metabolic Regulator. Front Endocrinol (Lausanne) 9:338
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893

Showing the most recent 10 out of 449 publications